ロード中...
Mild to Moderate Alzheimer Dementia with Insufficient Neuropathological Changes
Recently, ∼16% of participants in an anti-Aβ passive immunotherapy trial for mild-to-moderate Alzheimer disease (AD) had a negative baseline amyloid positron emission tomography (PET) scan. Whether they have AD or are AD clinical phenocopies remains unknown. We examined the 2005-2013 National Alzhei...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4016558/ https://ncbi.nlm.nih.gov/pubmed/24585367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.24125 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|